{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:29:02Z","timestamp":1790562542635,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11239-005-0341-x","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T11:09:58Z","timestamp":1112785798000},"page":"163-169","source":"Crossref","is-referenced-by-count":27,"title":["The Use of the Point of Care Helena ICHOR\/Plateletworks\u00ae and the Accumetrics Ultegra\u00ae RPFA for Assessment of Platelet Function with GPIIb-IIIa Antagonists"],"prefix":"10.1007","volume":"18","author":[{"given":"Melanie M.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajini","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddi J.","family":"Kueter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Jacoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00001573-200207000-00002","volume":"17","author":"DE Kandzari","year":"2002","unstructured":"Kandzari DE, Califf RM. TARGET versus GUSTO-IV: Appropriate use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention. Curr Opin Cardiol 2002;17:332\u2013339.","journal-title":"Curr Opin Cardiol"},{"key":"CR2","unstructured":"Jennings LK. Clinical trials of the parenteral glycoprotein IIb-IIIa inhibitors: The influence of dose selection on results. A CME Booklet, Health Science Communication, 2001."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.77.3.670","volume":"77","author":"HK Gold","year":"1988","unstructured":"Gold HK, Coller BS, Yasuda T, et al. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb\/IIIa antibody in a canine preparation. Circulation 1988;77:670\u2013677.","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"The EPIC Investigators","year":"1994","unstructured":"The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956\u2013961.","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","volume":"103","author":"SR Steinhubl","year":"2001","unstructured":"Steinhubl SR, Talley JD, Braden GA, et al. Point-of-Care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention. Circulation 2001;103:2572\u20132578.","journal-title":"Circulation"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S0002-8703(98)70246-7","volume":"135","author":"LK Jennings","year":"1998","unstructured":"Jennings LK, White MM. Expression of ligand-induced binding sites on glycoprotein IIb\/IIIa complexes and the effect of various inhibitors. Am Heart J 1998;135:S179\u201383.","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9149(99)00321-5","volume":"84","author":"DJ Kereiakes","year":"1999","unstructured":"Kereiakes DJ, Broderick TM, Roth EM, et al. Time course, magnitude and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Am J Cardiol 1999;84:391\u2013395.","journal-title":"Am J Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ccd.1096","volume":"52","author":"DI Simon","year":"2001","unstructured":"Simon DI, Liu CB, Ganz P, et al. A comparative study of light transmission aggregometry and automated bedside platelet function assay in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Cathet and Cardiovasc Intervent 2001;52:425\u2013432.","journal-title":"Cathet and Cardiovasc Intervent"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1067\/mhj.2002.121734","volume":"143","author":"GL Wheeler","year":"2002","unstructured":"Wheeler GL, Braden GA, Steinhubl SR, et al. The Ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy. Am Heart J 2002;143:602\u2013611.","journal-title":"Am Heart J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ccd.1179","volume":"53","author":"NM Lakkis","year":"2001","unstructured":"Lakkis NM, George S, Thomas E, Ali M, Guyer K, Carville D. Use of ICHOR-Platelet works to assess platelet function in patients treated with GP IIb\/IIIa inhibitors. Cathet and Cardiovasc Intervent 2001;53:346\u2013351.","journal-title":"Cathet and Cardiovasc Intervent"},{"issue":"suppl II","key":"CR11","first-page":"II-318","volume":"104","author":"L Nannizzi-Alaimo","year":"2001","unstructured":"Nannizzi-Alaimo L, Alves VL, Prasad KS, Stockett DE, Phillips DR. GPIIb-IIIa antagonists demonstrate a dose-dependent inhibition and potentiation of soluble CD40L (CD154) release during platelet stimulation. Circulation 2001;104(suppl II):II-318. Abstract No. 1533.","journal-title":"Circulation"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","volume":"106","author":"P Andre","year":"2002","unstructured":"Andre P, Nannizzi-Alaimo L, Srinivasa K, Prasad KS, Philips DR. Platelet-derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002;106:896\u2013899.","journal-title":"Circulation"},{"issue":"1","key":"CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1540-8183.2002.tb01034.x","volume":"15","author":"LK Jennings","year":"2002 Feb","unstructured":"Jennings LK, Jacoski MV, White MM. The pharmacodynamics of parenteral glycoprotein IIb\/IIIa inhibitors. J Interv Cardiol 2002 Feb;15(1):45\u201360, Review 10.","journal-title":"J Interv Cardiol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/01.CIR.96.5.1488","volume":"96","author":"DR Phillips","year":"1997","unstructured":"Phillips DR, Teng WS, Arfsten A, et al. Effect of Ca++ on Integrilin\u2122 GPIIb-IIIa interactions: Enhanced GPIIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 1997;96:1488\u20131494.","journal-title":"Circulation"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0049-3848(98)00163-7","volume":"92","author":"CK Li","year":"1998","unstructured":"Li CK, Hoffmann TJ, Hsieh PY, Malik S, Watson WC. The Xylum Clot Signature Analyzer: A dynamic flow system that simulates vascular injury. Thromb Res 1998;92:S67\u2013S77.","journal-title":"Thromb Res"},{"issue":"2","key":"CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2001.112489","volume":"141","author":"M Madan","year":"2001","unstructured":"Madan M, Berkowitz SD, Christie DJ, et al. Rapid assessment of glycoprotein IIb-IIIa blockade using the platelet function analyzer (PFA-100) during percutaneous coronary intervention. Am Heart J 2001;141(2):226\u2013233.","journal-title":"Am Heart J"},{"key":"CR17","first-page":"1710","volume":"100","author":"L Nannizzi-Alaimo","year":"1999","unstructured":"Nannizzi-Alaimo L, Rychel AL, Teng W, et al. Effect of citrate anticoagulation and platelet agonist concentration on the inhibitory activities of GPIIb-IIIa antagonists. Circulation 1999;100:1710.","journal-title":"Circulation"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1012991303381","volume":"12","author":"DJ Kereiakes","year":"2001","unstructured":"Kereiakes DJ, Lorenz TJ, Young JJ, et al. Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban. J Thromb Thrombolysis 2001;12:123\u2013127.","journal-title":"J Thromb Thrombolysis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.CIR.95.4.860","volume":"95","author":"BS Coller","year":"1997","unstructured":"Coller BS, Lang D, Scudder LE. Rapid and simple platelet function assay to assess glycoprotein IIb\/IIIa receptor blockade. Circulation 1997;95:860\u2013867.","journal-title":"Circulation"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","unstructured":"The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436\u2013443.","journal-title":"N Engl J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","volume":"357","author":"ML Simoons","year":"2001","unstructured":"Simoons ML, and the GUSTO IV-ACS Investigators. Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomized trial. Lancet 2001;357:1915\u20131924.","journal-title":"Lancet"},{"key":"CR22","doi-asserted-by":"crossref","unstructured":"Saucedo JF, Lui HK, Garza L, Guerra GJ, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: The TAM2 Study. J Thromb Thrombolysis, 2004(in press).","DOI":"10.1007\/s11239-004-0203-y"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.CIR.0000019581.22812.B2","volume":"106","author":"MJ Quinn","year":"2002","unstructured":"Quinn MJ, Plow EF, Topol EJ. Platelet glycoprotein IIb\/IIIa inhibitors: Recognition of a two-edged sword? Circulation 2002;106:379\u2013385.","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-0341-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-005-0341-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-0341-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:28Z","timestamp":1559372488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-005-0341-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1007\/s11239-005-0341-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}